US Patent Issued to Regeneron Pharmaceuticals on April 22 for "Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor" (New York Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,173, issued on April 22, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor" was invented by Viktoria Gusarova (Pleasantville, N.Y.), Jesper Gromada (Scarsdale, N.Y.) and Andrew J. Murphy (Croton-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating patients suffering from hypercholesterolemia, wherein the patient is non-responsive to, inadequately controlled by, or intolerant to treatment with a standard lipid modifying therapy. The methods of the in...